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Abstract
Background: Crigler-Najjar syndrome (CN) is a very rare genetic disorder characterized by an inability to conjugate
bilirubin. Contrary to CN type I, patients with CN II exhibit residual capacity to conjugate bilirubin and may present
a normal life expectancy.
Case presentation: We report an unusual late diagnosis of CN type II in an 80-year-old female admitted with
severe acute cholangitis. While the patient present typical clinical and radiologic signs of bile duct obstruction
and cholangitis, her blood analysis showed severe unconjugated hyperbilirubinemia. Endoscopic retrograde
cholangiopancreatography confirmed the diagnosis and allowed therapeutic intervention. The anatomopathologic
examination of her gallbladder following cholecystectomy showed signs of chronic cholecystitis.
Conclusion: The risk of gallstone disease may be increased in patients with CN syndrome. While unusual, we alert to
this curious and potential life-threatening presentation.
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Background
Crigler-Najjar syndrome (CN) is a rare autosomal reces-
sive disorder with an incidence estimated at 0.6 patients
per million [1]. It is characterized by impaired activity of
the hepatic enzyme uridine diphosphate-glucuronosyl-
transferase (UDP-GT). In CN type I there is a complete
absence of UDP-GT and these patients present with se-
vere accumulation of unconjugated bilirubin in basal
ganglia and cerebellum, leading to irreversible brain
damage in the first years of life [1]. Patients with CN
type II exhibit severe deficiency of UDP-GT enzyme ac-
tivity (below 30 %). It is a less severe form of the disease,
usually without neurological damage, although patients
may still require phototherapy and early liver transplant-
ation to improve quality of life. Mutations in UDP-GT
have been associated with an increased risk of gallstone
formation [2–8]. The underlying mechanism is believed
to involve increased levels of unconjugated bilirubin in
the bile leading to increased formation of calcium-
bilirubinate compounds [9]. In 1983, Trotman de-
scribed the first report of acute cholangitis secondary
to bile duct obstruction in a young patient with CN
type II [10]. In this paper, we report the second case
of acute cholangitis in a patient with CN type II. In
addition, we discuss this uncommon presentation in
an elderly patient, and review the available literature
on this disease.
Case presentation
An 80-year-old female patient was admitted to Santa
Maria Hospital’s emergency department with acute right
upper quadrant abdominal pain, fever, chills and vomit-
ing. Her medical history was relevant for CN type II,
systemic hypertension and type II diabetes mellitus.
Although she presented persistent jaundice since birth,
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the diagnosis of CN was only made in adulthood, based
only on clinical grounds. She had never required
treatment for CN. Seven years earlier, she had been
admitted to a different institution with cholecystitis
and gallstone pancreatitis. She underwent therapeutic
endoscopic retrograde cholangiopancreatography (ERCP)
with sphincterotomy. The patient declined cholecyst-
ectomy for personal reasons. A laboratory evaluation
requested by her general practitioner 5 years earlier
showed normal aspartate aminotransferase (AST) –
24 U/L (normal range < 34 U/L), gama-glutamyl-trans-
peptidase (GGT) - 30 U/L (normal range < 32 U/L), pro-
thrombin time – 11.6 s (normal range <11.8 s),
markedly increased total bilirubin - 11.7 mg/dl (normal
range <1.0 mg/dl), and only slightly elevated direct
bilirubin - 0.37 mg/dl (normal range <0.35 mg/dl). At
admission, physical examination showed fever (39 °C),
severe icterus and right upper quadrant tenderness.
Laboratory tests revealed signs of systemic inflamma-
tion (leukocytosis, elevated C-reactive protein) and a
cytocholestatic pattern with unusual elevation in total
bilirubin, but only a slight elevation of the direct frac-
tion. There was no evidence of hemolysis (Table 1).
Abdominal ultrasound demonstrated distention of the
gallbladder with marked wall thickening (10 mm),
pericholecystic fluid, positive sonographic Murphy's
sign and cholelithiasis. The intrahepatic and common
bile ducts were dilated (11 mm) and there was an
echogenic material within the common bile duct sug-
gestive of gallstones (Fig. 1). This was compatible
with acute obstructive cholangitis with cholecystitis.
After starting broad spectrum antibiotics, the patient
underwent emergency ERCP which revealed multiple
gallbladder and common bile duct stones. Following
exploration with basket and balloon, sludge and pus
were observed coming out from the papilla, thus con-
firming cholangitis (Fig. 2). The patient evolved un-
eventfully. By the 7th day of admission there was a
clear improvement in cholestasis (Table 2). She was
discharged after 10 days of hospitalization. Four
weeks later, the patient underwent elective laparo-
scopic cholecystectomy. The surgical specimen measured
7 × 3.5 cm. The gallbladder wall was moderately thick-
ened. The outer surface was partially rough, yellow-gray
with multiple hemorrhagic foci. The lumen exhibited mul-
tiple ovoid yellow-brown stones, the largest measuring
15 mm. Rokitansky–Aschoff sinuses could also be seen.
These findings were compatible with chronic calculous
cholecystitis.
Discussion
CN type II, unlike type I, is a potentially benign dis-
ease. Patients with this condition usually have serum
bilirubin levels ranging between 10 and 20 mg/dL
(175 and 350 μmol/l) and seldom develop kernicterus,
although neurological dysfunction may occur if hyper-
bilirubinemia is exacerbated by fasting, drugs or infec-
tious diseases [11]. There have been several published
reports of increased incidence of gallstones in patients
with UDP-GT mutations [2–5, 12]. In a series with
20 patients with CN type I followed over a 16-year
period, half developed cholelithiasis and required
Table 1 Laboratory evaluation at admission. Inflammatory
markers and acute renal failure is present. In addition a
cytocholestatic pattern is apparent with unusual disproportion
in total to direct bilirubin
Item Value Normal values
Hemoglobin (g/dL) 12.0 12.0–15.3
Leucocytes (x 109/L) 12.3 4.0–10.0
Neutrophils (x 109/L) 11.2 1.5–7.5
Platelets (x 109/L) 93 150–400
Creatinine (mg/dl) 2.0 0.6–1.3
CRP (mg/dl) 11.0 <0.5
LDH (UI/ml) 250 65–387
AST (U/L) 1085 (<34)
ALT (U/L) 934 (12–78)
GGT (U/L) 330 (<38)
Total bilirubin (mg/dL) 19.4 (<1.0)
Direct bilirubin (mg/dL) 2.71 (<0.3)
Haptoglobin (mg/dL) 234 (30–200)
Fig. 1 Abdominal ultrasound showing gallbladder wall thickening, pericholecystic fluid and cholelithiasis (a). The common bile duct is dilated (b)
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elective cholecystectomy [12]. Gallstones were de-
tected on cholecystography in 4 of 53 patients with
Gilbert’s disease by Foulk et al. [3] and required
cholecystectomy in 2 of 55 patients studied by Powell
et al. [2] In a series of cholecystectomy patients, Gilbert’s
disease was reported in 7.5 % of male patients [4].
Several explanations for this occurrence have been
suggested. One theory relates to the composition of
bile which is markedly abnormal in patients with
UDP-GT mutations [9, 13]. Due to the inability to
adequately conjugate bilirubin, the bile of patients
with UDP-GT mutations exhibits abnormal amounts
of bilirubin mono and diglucuronides. These com-
pounds are more prone to deconjugation by bacterial
glucuronidases. Unconjugated bilirubin combines with
bile calcium, leading to the formation of pigmented
gallstones [9, 13]. This however, may prove to be in-
sufficient as a physiopathological explanation, since
most reports of gallstones in patients with UDP-GT
mutations describe an additional factor such as cystic
fibrosis, sickle cell disease or spherocytosis [6–8].
Nevertheless, despite an elevated risk for gallstone
disease, we have only found one report of cholangitis
in a patient with CN type II [10]. Differentiation between
Gilbert’s disease and CN type I and II is important since
treatment and prognosis are different between these
entities. Although the diagnosis is usually made on
clinical grounds, response to phenobarbital (decrease
by at least 25 % in CN type II), bile analysis, meas-
urement of UDP-GT on liver tissue and genetic test-
ing can be used to confirm the diagnosis [14–17].
Interestingly, patients with atypical presentations pre-
venting a clear differentiation between type I and II
have been described, raising awareness for possible
phenotypes with incomplete penetration [18, 19]. Al-
though generally unnecessary, treatment options for
patients with CN type II include phototherapy [1],
plasmapheresis [20], enzyme induction with phenobar-
bital [4] and liver transplantation [1, 21]. Photother-
apy effectively decreased unconjugated bilirubin by
converting it to a water-soluble photoisomer that can
be excreted in the bile. This treatment is only tem-
porary as skin thickness and body surface area in-
crease with age, reducing its efficiency. Additionally,
phototherapy represents a heavy burden for the pa-
tient, requiring 10 to 12 h/day of treatment. The
average life expectancy for patients having type I syn-
drome is around 30 years [21]. Even though the prog-
nosis of CN type II is usually good and is compatible
with a normal life span, repeated episodes of kernic-
terus may culminate in permanent neurological dam-
age [22, 23]. The present case seemed of great
interest due to the rarity of the situation, and also be-
cause of the advanced age of presentation, with the
patient only presenting this frequent complication at
this old age. Aside from the episode of acute gall-
stone pancreatitis, 7 years earlier, no other significant
complications of the prolonged hyperbilirubinemia
were seen in her lifetime.
Conclusion
CN patients are at an increased risk for gallstones and
associated complications. This is the second report of
cholangitis in a patient with CN, nevertheless, as cholan-
gitis is potentially fatal if unrecognized and left un-
treated, clinicians should be aware of this possibility and
endeavor to exclude it early. As these patients are per-
manently jaundiced, we cannot rely solely on this sign to
diagnose cholangitis. In addition, the literature suggests
that pigmented gallstones may follow in the long-term
of mild cases of CN.
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Fig. 2 Endoscopic retrograde cholangiopancreatography showing
multiple stones in the gallbladder (arrow)
Table 2 Laboratory results at discharge. There is a clear
improvement in the liver panel
Item Value Normal values
AST (U/L) 21 (<34)
GGT (U/L) 116 (<38)
Total bilirubin (mg/dL) 15.6 (<1.0)
Direct bilirubin (mg/dL) 1.1 (<0.3)
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